Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGVP.L Regulatory News (GVP)

  • There is currently no data for GVP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Open Letter to Associated Capital Group, Inc.

15 Oct 2020 17:46

Metage Capital Limited - Open Letter to Associated Capital Group, Inc.

Metage Capital Limited - Open Letter to Associated Capital Group, Inc.

PR Newswire

London, October 15

Metage Capital Limited: open letter to Associated Capital Group, Inc.

Mr Bruce LismanAssociated Capital Group, Inc.191 Mason StreetGreenwich, CT 06830

For Immediate Release

15th October 2020

Dear Mr Lisman,

Re: respecting the vote by shareholders to discontinue the Gabelli Value Plus+ Trust Plc. (“GVP”)

On 6th October 2020 you held a webinar setting out the position of Associated Capital Group, Inc. (“ACG”) on the continuation of GVP. When signing up to this webinar, investors were asked to submit questions, however none were addressed. We have been dissatisfied by the subsequent response from ACG to the questions that we asked and believe that other shareholders would share similar queries. We therefore ask you to respond publicly to the following:

1. In the GVP announcement of 6th October, the Board of GVP refers to “…a letter received by the Board from the general counsel to ACG on 2 October 2020 indicating that (unspecified) litigation concerning the company may be a distinct possibility…” Can you please explain why ACG is threatening legal action, what potential illegality or breach of contract you perceive and what the aim of this litigation would be?

2. The “Magna Carta of shareholder Rights” on Gabelli Investors, Inc.’s website[1] states that it is in favour of “one share: one vote” and that “…we will vote against…supermajority voting…” How is attempting to frustrate the will of a clear majority of shareholders consistent with Gabelli’s corporate governance principles?

3. The Board has offered the potential of an in specie redemption of ACG’s pro rata share of the GVP portfolio or the ability to provide ACG with a roll over vehicle with a similar strategy and manager. This would enable ACG to continue its investment without frustrating the desire of other shareholders for a cash exit. How would you justify attempting to trap the majority of shareholders against their will?

Finally we would like to thank the Board of GVP for their steadfastness in a difficult situation, which is an excellent demonstration of the highest standards of corporate governance in London-listed investment trusts.

Yours faithfully,Tom Sharp, DirectorMetage Capital LimitedPrinces House, 38 Jermyn Street, London SW1Y 6DN, United KingdomEmail: tom.sharp@metage.comTel: +(44) 203 813 8590

[1] https://www.gabelli.co.uk/wp-content/uploads/2015/01/magnacarta092403.pdf

Date   Source Headline
28th Jan 20219:00 amRNSNet Asset Value(s)
27th Jan 20219:00 amRNSNet Asset Value(s)
26th Jan 20219:00 amRNSNet Asset Value(s)
25th Jan 20219:00 amRNSNet Asset Value(s)
22nd Jan 20219:00 amRNSNet Asset Value(s)
21st Jan 20211:19 pmRNSDividend Declaration
21st Jan 20219:00 amRNSNet Asset Value(s)
20th Jan 20219:43 amRNSNet Asset Value(s)
19th Jan 20219:15 amRNSNet Asset Value(s)
18th Jan 202110:08 amRNSNet Asset Value(s)
15th Jan 20219:00 amRNSNet Asset Value(s)
15th Jan 20217:00 amRNSProposals for Future of Company
15th Jan 20217:00 amRNSHolding(s) in Company
14th Jan 202110:25 amRNSNet Asset Value(s)
13th Jan 20219:00 amRNSNet Asset Value(s)
12th Jan 20219:00 amRNSNet Asset Value(s)
11th Jan 20213:28 pmRNSNet Asset Value(s)
8th Jan 20218:34 amRNSNet Asset Value(s)
7th Jan 20219:02 amRNSNet Asset Value(s)
6th Jan 20219:34 amRNSNet Asset Value(s)
5th Jan 20214:03 pmRNSListing Rule 15.6.8
5th Jan 20213:40 pmRNSHolding(s) in Company
5th Jan 20219:29 amRNSNet Asset Value(s)
5th Jan 20217:00 amRNSHalf-year Report
4th Jan 20218:46 amRNSNet Asset Value(s)
31st Dec 20209:20 amRNSNet Asset Value(s)
30th Dec 20209:08 amRNSNet Asset Value(s)
29th Dec 20209:55 amRNSNet Asset Value(s)
24th Dec 202010:01 amRNSNet Asset Value(s)
23rd Dec 20209:00 amRNSNet Asset Value(s)
22nd Dec 20209:08 amRNSNet Asset Value(s)
21st Dec 20209:22 amRNSNet Asset Value(s)
18th Dec 20209:00 amRNSNet Asset Value(s)
17th Dec 20209:48 amRNSNet Asset Value(s)
16th Dec 20209:00 amRNSNet Asset Value(s)
15th Dec 20209:00 amRNSNet Asset Value(s)
14th Dec 20209:00 amRNSNet Asset Value(s)
11th Dec 20209:00 amRNSNet Asset Value(s)
10th Dec 20201:56 pmRNSHolding(s) in Company
10th Dec 202010:09 amRNSNet Asset Value(s)
9th Dec 20209:00 amRNSNet Asset Value(s)
8th Dec 20204:54 pmRNSNet Asset Value(s)
7th Dec 20205:44 pmRNSResult of General Meeting
7th Dec 20209:00 amRNSNet Asset Value(s)
4th Dec 20209:00 amRNSNet Asset Value(s)
3rd Dec 20203:16 pmRNSHolding(s) in Company
3rd Dec 20209:00 amRNSNet Asset Value(s)
2nd Dec 20209:00 amRNSNet Asset Value(s)
1st Dec 20209:00 amRNSNet Asset Value(s)
30th Nov 20209:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.